1 / 35

The Neurobiology of Nicotine Dependence and Co-Morbid Psychiatric Disorders

The Neurobiology of Nicotine Dependence and Co-Morbid Psychiatric Disorders. George F. Koob, Ph.D. Athina Markou, Ph.D. Department of Neuropharmacology The Scripps Research Institute La Jolla, California. Criteria for Substance Dependence (DSM-IV).

Leo
Download Presentation

The Neurobiology of Nicotine Dependence and Co-Morbid Psychiatric Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Neurobiology of Nicotine Dependence and Co-Morbid Psychiatric Disorders George F. Koob, Ph.D. Athina Markou, Ph.D. Department of Neuropharmacology The Scripps Research Institute La Jolla, California

  2. Criteria for Substance Dependence (DSM-IV) From: Koob GF and Le Moal M, Science, 1997, 278:52-58.

  3. Acute Nicotine Increases Brain Stimulation Reward From: Huston-Lyons D and Kornetsky C, Pharmacol Bioch Behav, 1992, 41:755-759.

  4. Nicotine Self-Administration Human data adapted from: Henningfield JR, Miyasato K and Jasinski DR, Pharmacol Biochem Behav 1983, 19:887-890.

  5. From: Watkins SS, Epping-Jordan MP, Koob GF and Markou A, Pharmacol Biochem Behav, 1999, 62:743-751.

  6. Effects of DHbE on Nicotine Self-Administration in Rats(0.03 mg/injection) From: Watkins SS, Epping-Jordan MP, Koob GF and Markou A, Pharmacol Biochem Behav, 1999, 62:743-751

  7. Key Neurochemical Systems Comprising Brain Drug Reward Circuitry

  8. Effects of 6-OHDA or Vehicle Infusions into theNucleus Accumbens on Nicotine Self-Administration in Rats From: Corrigall WA, Franklin FBJ, Coen KM, and Clarke PBS, Psychopharmacology, 1992, 107:285-289.[

  9. Mechanisms by which Nicotine Interacts with Dopamine and Glutamate Transmission Nicotine activates nAChRs located on glutamate terminals in the ventral tegmental area (VTA) Nicotine-stimulated glutamate release acts at glutamate receptors located on VTA dopamine neurons Activation of glutamate receptors stimulates dopamine release into terminal regions, such as the nucleus accumbens From: Kelley AE, Nature Med, 2002, 8:477-479.

  10. Dependence:An Affective Definition “The notion of dependence on a drug, object, role, activity or any other stimulus-source requires the crucial feature of negative affect experienced in its absence. The degree of dependence can be equated with the amount of this negative affect, which may range from mild discomfort to extreme distress, or it may be equated with the amount of difficulty or effort required to do without the drug, object, etc.” From: Russell MAH, What is dependence? In Edwards G (ed), Drugs and Drug Dependence, Lexington Books, Lexington, MA, 1976, pp. 182-187.

  11. Withdrawal from nicotine elicits an aversive behavioral syndrome in humans • Gastro-intestinal discomfort • Bradycardia • Increased appetite • Anxiety • Depressed Mood • Craving • Dysphoria • Irritability • Difficulty concentrating

  12. ICSS Threshold Procedure Adapted from: Markou A and Koob GF, Physiol Behav, 1992, 51:111-119.

  13. Spontaneous Nicotine Withdrawal Adapted from: Epping-Jordan MP, Watkins SS, Koob GF and Markou A, Nature, 1998, 393:76-79.

  14. DHE-precipitated Nicotine Withdrawal From: Epping-Jordan MP, Watkins SS, Koob GF and Markou A, Nature, 1998, 393:76-79.

  15. Brain Reward Function During Acute Withdrawal(0-72 hours)

  16. Decreases in Extracellular Levels of DopamineDuring Precipitated Nicotine Withdrawal From: Hildebrand BE, Nomikos GG, Hertel P, Schilstrom B and Svensson TH, Brain Res, 1998, 779:214-225. From: Panagis G, Hildebrand BE, Svensson TH and Nomikos GG, Synapse, 2000, 35:15-25.

  17. Effects of Nicotine and a Nicotinic Antagonist Injected into the Dorsal Raphe Nucleus on the Social Interaction Test From: Cheeta S, Tucci S and File SE, Pharmacol Biochem Behav, 2001, 70:491-496.

  18. Nicotine Withdrawal From: Harrison AA, Liem YTB and Markou A, Neuropsychopharmacology, 2001, 25:55-71.

  19. The mGluII Receptor Antagonist LY341495 Reversed Spontaneous Nicotine Withdrawal From: Kenny PJ, Gasparini F and Markou A, unpublished results.

  20. Glutamatergic and GABAergic regulation of dopamine transmission in the VTA Glutamate Terminal VTA Dopamine Neuron Pre-synaptic Modulation Post-synaptic Modulation Adapted from: Schoepp DD, J Pharmacol Exp Ther, 2001, 299:12-20.

  21. CNS Actions of Corticotropin Releasing Factor (CRF)

  22. Neurotransmitter Systems Hypothesized to be Involved in the Motivational Aspects of Nicotine Withdrawal Acetylcholinepedunculopontine tegmental nucleus Dopaminenucleus accumbens, amygdala Opioid Peptidesnucleus accumbens, amygdala, ventral tegmental area Serotoninmedian raphe Glutamateventral tegmental area Corticotropin-Releasing Factor (???) Lanca et al., 2000 Hildebrand et al., 1999Pangis et al., 2000 Malin et al., 1993Ise et al., 2000Watkins et al., 2000 Harrison et al., 2001Cheeta et al., 2001 Kenny et al., 2001

  23. Depression and Withdrawal from a Variety of Drugsof Abuse are Associated with Altered Function inSeveral Neurotransmitter Systems 5-HT NE or Ach DA GABA CRF NPY SS Opioids Depression Drug withdrawal Psychostimulants Opiates Ethanol Nicotine ?

  24. Hypothetical Anatomical Circuit Underlying Melancholic Depression and Adversity From: Schulkin J, McEwen BS and Gold PW, Neurosci Biobehav Rev, 1994, 18:385-396.

  25. Hypothetical Anatomical Circuit Underlying the “Dark Side” of Drug Dependence

  26. The Atypical Antidepressant Bupropion Reversed Nicotine Withdrawal Cryan, Bruijnzeel, Skjei & Markou, Psychopharmacology, 168:347-358, 2003

  27. Allostatic Change in Mood State associated with Transition to Drug Addiction From: Koob GF and Le Moal M, Neuropsychopharmacology, 2001, 24:97-129.

  28. Modified from: Heimer L and Alheid G, Piecing together the puzzle of basal forebrain anatomy. In: Napier TC, Kalivas PW and Hanin I (Eds), The Basal Forebrain: Anatomy to Function (series title: Advances in Experimental Medicine and Biology, Vol. 295), Plenum Press, New York, 1991, pp. 1-42. Potential Substrates in the Extended Amygdala for the Motivational Effects of Drug Dependence

  29. Summary and Conclusions • Nicotine is readily self-administered by animals and enhances brain reward • Neurochemical substrates important for the acute reinforcing effects of nicotine include dopamine, GABA, opioid peptides, serotonin, and glutamate systems in the basal forebrain. • The focus of research to date on the acute reinforcing effects of nicotine has been on specific nicotinic receptor dynamics in the context of glutamate/GABA interactions with dopamine neurons in the ventral tegmental area. • Development of “motivational” dependence to nicotine is associated with dysregulation of the brain reward system and decreased function in some of the same neurochemical systems involved in negative affect associated with co-morbid psychiatric disorders

  30. Collaborators Athina Markou John Cryan Mark Epping-Jordan Amanda Harrison Paul Kenny Laura O’ Dell Neil Paterson Svetlana Semenova Luis Stinus Shelly Watkins • Support from the National Institute on Drug Abuse and National Institute on Mental Health • Research Grant from Novartis • Support from the Tobacco Etiology Research Network of the Robert Wood Johnson Foundation • Support from the Tobacco-Related Disease Research Program, State of California

  31. Summary and Conclusions (What is unknown) • The reward dysregulation of early and late withdrawal from nicotine is hypothesized to result from “allostatic”, rather than homeostatic, changes in the brain reward circuitry. • The “dark side” of dependence to nicotine may also involve the recruitment of changes in the brain stress systems including corticotropin releasing factor and/or norepinephrine. • The subdivisions of the extended amygdala provide a heuristic framework for integrating the hypothesis that normal motivational function is usurped by chronic drugs of abuse to produce a deficit emotional state associated with addiction. • Neuropharmacological changes in the circuits of the extended amygdala may persist during protracted withdrawal and provide a motivational basis for vulnerability to co-morbid psychiatric disorders.

More Related